Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing etanercept (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Etanercept (substance) |
Inferred relationship |
Some |
1 |
Etanercept 25mg powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Etanercept (substance) |
Inferred relationship |
Some |
|
Etanercept 25mg/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Etanercept (substance) |
Inferred relationship |
Some |
|
Etanercept 25mg/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Etanercept (substance) |
Inferred relationship |
Some |
|
Etanercept 50mg powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Etanercept (substance) |
Inferred relationship |
Some |
|
Etanercept 50mg/mL injection solution 0.98mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Etanercept (substance) |
Inferred relationship |
Some |
|
Etanercept therapy |
Direct substance |
True |
Etanercept (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely etanercept 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Etanercept (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely etanercept 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Etanercept (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely etanercept 25 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Etanercept (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely etanercept 25 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Etanercept (substance) |
Inferred relationship |
Some |
1 |
Etanercept-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Etanercept (substance) |
Inferred relationship |
Some |
1 |
Product containing only etanercept (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Etanercept (substance) |
Inferred relationship |
Some |
1 |
Product containing only etanercept in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Etanercept (substance) |
Inferred relationship |
Some |
1 |
Etanercept 50 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Etanercept (substance) |
Inferred relationship |
Some |
1 |
Etanercept 50 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Etanercept (substance) |
Inferred relationship |
Some |
1 |
Etanercept 10 mg powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Etanercept (substance) |
Inferred relationship |
Some |
1 |
Etanercept 10 mg powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Etanercept (substance) |
Inferred relationship |
Some |
1 |
Etanercept 49.01 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Etanercept (substance) |
Inferred relationship |
Some |
1 |
Etanercept 49.01 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Etanercept (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely etanercept 51.02 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Etanercept (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely etanercept 51.02 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Etanercept (substance) |
Inferred relationship |
Some |
1 |